F5 INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Urges F5 Investors to Contact the Firm Regarding Investigation

F5 INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Urges F5 Investors to Contact the Firm Regarding Investigation GlobeNewswire October 28, 2025 Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In F5 (FFIV) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in F5 and […]

First Quantum Minerals Reports Third Quarter 2025 Results

First Quantum Minerals Reports Third Quarter 2025 Results (In United States dollars, except where noted otherwise) GlobeNewswire October 28, 2025 TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“First Quantum” or the “Company”) (TSX: FM) today reports results for the three and nine months ended September 30, 2025 (“Q3 2025” or the

UniFirst Declares Increased Cash Dividends

(NYSE:UNF), WILMINGTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — The Board of Directors of UniFirst Corporation (NYSE:UNF) today declared increased quarterly cash dividends of $0.365 per share (36.5 cents) on the Company's Common Stock and $0.292 per share (29.2 cents) on the Company's Class B Common Stock. Both dividends are payable on January 2, 2026

Itafos Announces Release Date for Q3 2025 Results and Business Update Webcast

(TSX-V:IFOS),(OTC US:ITFS),(OTCQX:ITFS), HOUSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) — Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (“Itafos” or “the Company”) today announces that its financial results for Q3 2025 will be released after market close on Wednesday, November 5, 2025. An on-demand recorded webcast of management commentary that reviews the Q3 2025 financial results, provides an

GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting(R) 2025

(Paris:GNFT), Several posters and presentations featuring new data on three ACLF programs, including G1090N (NTZ reformulation) disease model data, new real-world data and biomarker insights in cirrhosis New Iqirvo(R) PBC and PSC data to be presented by partner Ipsen, underscoring its potential in rare cholestatic liver diseases Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland),

UniFirst Declares Increased Cash Dividends

UniFirst Declares Increased Cash Dividends GlobeNewswire October 28, 2025 WILMINGTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) — The Board of Directors of UniFirst Corporation (NYSE:UNF) today declared increased quarterly cash dividends of $0.365 per share (36.5 cents) on the Company's Common Stock and $0.292 per share (29.2 cents) on the Company's Class B Common Stock.

GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting(R) 2025

GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting(R) 2025 GlobeNewswire October 28, 2025 Several posters and presentations featuring new data on three ACLF programs, including G1090N (NTZ reformulation) disease model data, new real-world data and biomarker insights in cirrhosis New Iqirvo(R) PBC and PSC data to be presented by partner Ipsen,

Itafos Announces Release Date for Q3 2025 Results and Business Update Webcast

Itafos Announces Release Date for Q3 2025 Results and Business Update Webcast GlobeNewswire October 28, 2025 HOUSTON, Oct. 28, 2025 (GLOBE NEWSWIRE) — Itafos Inc. (TSX-V: IFOS) (OTCQX: ITFS) (“Itafos” or “the Company”) today announces that its financial results for Q3 2025 will be released after market close on Wednesday, November 5, 2025. An on-demand

Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) Notification of Sources of Distribution Under Section 19(a)

This press release provides shareholders of Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) (the “Fund”) with information regarding the sources of the distribution to be paid on October 31, 2025 and cumulative distributions paid fiscal year-to-date. In December 2021, the Fund implemented a managed distribution policy in accordance with exemptive relief issued by

INVESTOR ALERT: Investigation of Vera Bradley, Inc. (VRA) Announced by Holzer & Holzer, LLC

(NASDAQ:VRA), ATLANTA, Oct. 28, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Vera Bradley, Inc. (“Vera Bradley” or the “Company”) (NASDAQ: VRA) complied with federal securities laws. On June 11, 2025, Vera Bradley announced financial results for the first quarter of fiscal 2026. The CEO commented on the results, stating they were

Scroll to Top